Of note, a significant cooperative growth inhibition could only be observed in MPN-BP samples, not in normal CD34+ cells demonstrating a disease specific therapeutic index despite comparable knockdown efficiency (Fig. 3E, Supplementary Fig. 1C and 2G). The gene discussed is CD34; the disease is myeloproliferative neoplasm.